Bernard Meignier

Title: Bernard Meignier: Innovator in Immunology

Introduction

Bernard Meignier is a notable inventor based in Thurins, France. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of 2 patents, Meignier's work focuses on enhancing immune responses and improving vaccine effectiveness.

Latest Patents

One of his latest patents is titled "Use of poxviruses as enhancer of specific immunity." This invention relates to a method for enhancing the specific immune response against an immunogenic compound. It involves administering the immunogenic compound alongside a poxvirus recombinant and a vaccinal antigen that is not a poxvirus. The immunological material can include various biological materials useful as vaccines, such as polypeptides characteristic of pathogenic microorganisms or tumor-associated antigens. The poxvirus may be live, attenuated, or inactivated, and can encode heterologous or homologous polypeptides that are immunologically cross-reactive with the immunogenic polypeptide.

Another significant patent is "Vaccine composition against influenza, with synergic effects, containing." This patent describes the use of an additive, which consists of a core or core fraction of at least one influenza virus, when preparing a vaccine composition containing a standard influenza virus vaccine. The additive improves the vaccine's effectiveness, showcasing Meignier's commitment to advancing vaccine technology.

Career Highlights

Throughout his career, Bernard Meignier has worked with prominent companies in the pharmaceutical and vaccine sectors. Notable organizations include Pasteur Merieux Serums Et Vaccins and Aventis Pasteur S.A. His experience in these companies has contributed to his expertise in vaccine development and immunology.

Collaborations

Meignier has collaborated with several professionals in his field, including Catherine Moste-Deshairs and Michel Chevalier. These collaborations have likely enriched his research and innovation efforts.

Conclusion

Bernard Meignier is a distinguished inventor whose work in immunology has led to significant advancements in vaccine technology. His innovative patents reflect his dedication to enhancing immune responses and improving public health outcomes.